355 related articles for article (PubMed ID: 1840099)
1. Biochemical and molecular aspects of late-onset GM2-gangliosidosis: B1 variant as a prototype.
Suzuki K; Vanier MT
Dev Neurosci; 1991; 13(4-5):288-94. PubMed ID: 1840099
[TBL] [Abstract][Full Text] [Related]
2. GM2-gangliosidosis B1 variant: analysis of beta-hexosaminidase alpha gene abnormalities in seven patients.
Tanaka A; Ohno K; Sandhoff K; Maire I; Kolodny EH; Brown A; Suzuki K
Am J Hum Genet; 1990 Feb; 46(2):329-39. PubMed ID: 2137287
[TBL] [Abstract][Full Text] [Related]
3. Molecular and clinical heterogeneity of adult GM2 gangliosidosis.
Navon R
Dev Neurosci; 1991; 13(4-5):295-8. PubMed ID: 1840100
[TBL] [Abstract][Full Text] [Related]
4. Biochemical consequences of mutations causing the GM2 gangliosidoses.
Mahuran DJ
Biochim Biophys Acta; 1999 Oct; 1455(2-3):105-38. PubMed ID: 10571007
[TBL] [Abstract][Full Text] [Related]
5. [GM2-Gangliosidosis variant B1 disclosed during adolescence by an isolated multi-systemic involvement of the central and peripheral nervous systems].
Le Coz P; Assouline E; Vanier MT; Goutières F; Mikol J; Woimant F; Pinard JM; Aicardi J; Haguenau M
Rev Neurol (Paris); 1994; 150(1):61-6. PubMed ID: 7801043
[TBL] [Abstract][Full Text] [Related]
6. Introduction of the alpha subunit mutation associated with the B1 variant of Tay-Sachs disease into the beta subunit produces a beta-hexosaminidase B without catalytic activity.
Brown CA; Neote K; Leung A; Gravel RA; Mahuran DJ
J Biol Chem; 1989 Dec; 264(36):21705-10. PubMed ID: 2532211
[TBL] [Abstract][Full Text] [Related]
7. GM2-gangliosidosis B1 variant: analysis of beta-hexosaminidase alpha gene mutations in 11 patients from a defined region in Portugal.
dos Santos MR; Tanaka A; sá Miranda MC; Ribeiro MG; Maia M; Suzuki K
Am J Hum Genet; 1991 Oct; 49(4):886-90. PubMed ID: 1832817
[TBL] [Abstract][Full Text] [Related]
8. [Tay-Sachs disease].
Tanaka A
Nihon Rinsho; 1993 Sep; 51(9):2281-5. PubMed ID: 8411703
[TBL] [Abstract][Full Text] [Related]
9. Genetic complementation in somatic cell hybrids of four variants of infantile GM2 gangliosidosis.
Sonderfeld S; Brendler S; Sandhoff K; Galjaard H; Hoogeveen AT
Hum Genet; 1985; 71(3):196-200. PubMed ID: 2933318
[TBL] [Abstract][Full Text] [Related]
10. Prenatal diagnosis of GM2 gangliosidosis with high residual hexosaminidase A activity (variant B1; pseudo AB variant).
Conzelmann E; Nehrkorn H; Kytzia HJ; Sandhoff K; Macek M; Lehovský M; Elleder M; Jirásek A; Kobilková J
Pediatr Res; 1985 Nov; 19(11):1220-4. PubMed ID: 2933632
[TBL] [Abstract][Full Text] [Related]
11. [Recent advances in molecular genetics of GM2 gangliosidosis].
Wakamatsu N
Nihon Rinsho; 1995 Dec; 53(12):2988-93. PubMed ID: 8577047
[TBL] [Abstract][Full Text] [Related]
12. Heterozygosity for the "DN allele" (G533-greater than A) of the beta-hexosaminidase alpha subunit gene identified by direct DNA sequencing in a family with the B1 variant of GM2-gangliosidosis.
Whitley CB; Anderson RA; McIvor RS
Neuropediatrics; 1992 Apr; 23(2):96-101. PubMed ID: 1318511
[TBL] [Abstract][Full Text] [Related]
13. Presence of beta-hexosaminidase A alpha-chain mRNA in two different variants of GM2-gangliosidosis.
Budde-Steffen C; Steffen M; Siegel DA; Suzuki K
Neuropediatrics; 1988 May; 19(2):59-61. PubMed ID: 2967444
[TBL] [Abstract][Full Text] [Related]
14. Molecular basis of adult-onset and chronic GM2 gangliosidoses in patients of Ashkenazi Jewish origin: substitution of serine for glycine at position 269 of the alpha-subunit of beta-hexosaminidase.
Paw BH; Kaback MM; Neufeld EF
Proc Natl Acad Sci U S A; 1989 Apr; 86(7):2413-7. PubMed ID: 2522660
[TBL] [Abstract][Full Text] [Related]
15. The clinical aspects of adult hexosaminidase deficiencies.
Federico A; Palmeri S; Malandrini A; Fabrizi G; Mondelli M; Guazzi GC
Dev Neurosci; 1991; 13(4-5):280-7. PubMed ID: 1840098
[TBL] [Abstract][Full Text] [Related]
16. Plasma G
Blondel A; Kraoua I; Marcelino C; Khrouf W; Schlemmer D; Ganne B; Caillaud C; Fernández-Eulate G; Turki IBY; Dauriat B; Bonnefont-Rousselot D; Nadjar Y; Lamari F
Mol Genet Metab; 2023 Feb; 138(2):106983. PubMed ID: 36709536
[TBL] [Abstract][Full Text] [Related]
17. Prenatal diagnosis of GM2-gangliosidosis B1 variant.
Lemos M; Pinto R; Ribeiro G; Ribeiro H; Lopes L; Sá Miranda MC
Prenat Diagn; 1995 Jun; 15(6):585-8. PubMed ID: 7659693
[TBL] [Abstract][Full Text] [Related]
18. Apoptotic cell death in mouse models of GM2 gangliosidosis and observations on human Tay-Sachs and Sandhoff diseases.
Huang JQ; Trasler JM; Igdoura S; Michaud J; Hanal N; Gravel RA
Hum Mol Genet; 1997 Oct; 6(11):1879-85. PubMed ID: 9302266
[TBL] [Abstract][Full Text] [Related]
19. Clinical, enzymatic, and molecular characterisation of a Portuguese family with a chronic form of GM2-gangliosidosis B1 variant.
Ribeiro MG; Sonin T; Pinto RA; Fontes A; Ribeiro H; Pinto E; Palmeira MM; Sá Miranda MC
J Med Genet; 1996 Apr; 33(4):341-3. PubMed ID: 8730294
[TBL] [Abstract][Full Text] [Related]
20. The Val192Leu mutation in the alpha-subunit of beta-hexosaminidase A is not associated with the B1-variant form of Tay-Sachs disease.
Hou Y; Vavougios G; Hinek A; Wu KK; Hechtman P; Kaplan F; Mahuran DJ
Am J Hum Genet; 1996 Jul; 59(1):52-8. PubMed ID: 8659543
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
